Emerging treatments
Targeted molecular therapies
Antiangiogenic therapies, hypoxia-inducible factor (HIF) inhibitors, mTOR inhibitors, tyrosine kinase inhibitors, DNA-alkylating agents, and immunotherapies are all under investigation for the treatment of pheochromocytomas.[82][91]
HSP90 inhibitors
Research has indicated that heat shock protein 90 (HSP90) is over-expressed in malignant pheochromocytomas. New drugs have been developed to specifically inhibit HSP90, which may in the future play a role in treatment of malignant pheochromocytomas.[92]
Use of this content is subject to our disclaimer